Angelalign Technology Inc. announced that a preliminary ruling by the Unified Patent Court of Düsseldorf, Germany, requires it to cease using certain software functions that automatically update treatment plans in specific European countries. The ruling does not affect users in Spain, Switzerland, the United Kingdom, or Ireland. Angelalign stated that the impact on orthodontists and patients will be minimal, as it will introduce the iPlan upgrade feature for affected European users, offering similar reliability and greater flexibility. The company denies infringing on any valid patents of Align Technology Inc. and has filed an opposition with the European Patent Office, seeking to invalidate the patent in question. Angelalign remains committed to compliance and to providing innovative solutions in the clear aligner market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Angelalign Technology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260212616683) on February 12, 2026, and is solely responsible for the information contained therein.